| Twist Bioscience | |
| Type: | Public |
| Industry: | synthetic biology |
| Products: | Genes and gene fragments, NGS products |
| Location City: | South San Francisco, California |
| Revenue: | $54.2 million(2019)[1] |
| Num Employees: | 400 |
Twist Bioscience is a public biotechnology company based in South San Francisco that manufactures synthetic DNA and DNA products for customers in a wide range of industries.[2] Twist was founded in 2013 by Emily Leproust, Bill Banyai, and Bill Peck.
The company was represented by Leproust at a March 2021 tabletop exercise at the Munich Security Conference simulating an outbreak of weaponized monkeypox.[3]
In May 2021, Twist Bioscience and Genome Project-Write launched a new CAD platform for whole genome design. The CAD will automate workflows to enable collaborative efforts critical for scale-up from designing plasmids to megabases across entire genomes.[4]